Summary
- Current Price
- As of today, ARQT price is $23.63, down -1.95% on
- Current Price All-Time High
- ARQT price is currently -42.20% below its historical high of $40.88 set on
- Market Cap
- ARQT current market cap is $3B, up +46.36% over the past 365 days
- PE Ratio
- ARQT PE ratio is unknown
- Revenue
- ARQT current annual revenue is $376.07M, up +91.34% year-over-year
- Next Earnings
- The next earnings release for ARQT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Arcutis Biotherapeutics, Inc. |
| Ticker | NASDAQ: ARQT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arcutis.com |
| Employees | 342 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $23.63 | |
| Price, 1D Change | -1.95% | |
| $3B | ||
| - | ||
| - | ||
| 1.16 | ||
| $376M | ||
| Revenue, 1Y Change | +91.34% | |
| -$0.13 | ||
| EPS, 1Y Change | +89.04% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.13 | ||
| EPS Estimate | N/A | $0.37 |
| EPS Est. Change | N/A | +389.28% |
| $376.07M | ||
| Revenue Estimate | N/A | $495.76M |
| Revenue Est. Change | N/A | +31.82% |
| Current Price | $23.63 | |
| Price Target | - | $35.00 |
| Price Tgt. Change | - | +48.12% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.34 | -$1.16 | +13.60% | |
| -$0.14 | -$0.13 | +7.44% | |
| $0.37 | N/A | +389.28% | |
| $1.28 | N/A | +1,107.57% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $185.49M | $196.54M | +5.96% | |
| $360.31M | $376.07M | +4.37% | |
| $495.76M | N/A | +31.82% | |
| $643.34M | N/A | +71.07% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $23.63 | |
| $21.89 | ||
| SMA 200 vs Price | -7.36% | |
| $24.88 | ||
| SMA 50 vs Price | +5.30% | |
| 1.16 | ||
| $1.16 | ||
| 50.26 | ||
| 70.48% | ||
| 59.21% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $376.07M | ||
| -$0.13 | ||
| $339.38M | ||
| 90.24% | ||
| -$12.23M | ||
| -3.25% | ||
| -$16.14M | ||
| -4.29% | ||
| -$6.86M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.60 | ||
| 3.17 | ||
| 2.99 | ||
| - | ||
| 3 | ||
| 5.01 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 7.70 | ||
| 15.28 | ||
| -415.60 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $189.48M | ||
| $221.29M | ||
| $432.97M | ||
| $411.23M | ||
| $243.49M | ||
| $129.84M | ||
| $114.23M | ||
| $1.00M | ||
| $12.53M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $392.21M | ||
| $351.60M | ||
| $36.70M | ||
| $0.00 | ||
| $4.67M | ||
| $0.00 | ||
| $1.17M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$5.63M | ||
| -$30.25M | ||
| $6.97M | ||
| $10.69M | ||
| -$16.31M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Mizuho | → | |
| Guggenheim | → | |
| TD Cowen | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Mizuho | → | |
| Goldman Sachs | → | |
| Needham | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with ARQT
FAQ
What is the ticker symbol for Arcutis Biotherapeutics, Inc.?
The ticker symbol for Arcutis Biotherapeutics, Inc. is NASDAQ:ARQT
Does Arcutis Biotherapeutics, Inc. pay dividends?
No, Arcutis Biotherapeutics, Inc. does not pay dividends
What sector is Arcutis Biotherapeutics, Inc. in?
Arcutis Biotherapeutics, Inc. is in the Healthcare sector
What industry is Arcutis Biotherapeutics, Inc. in?
Arcutis Biotherapeutics, Inc. is in the Biotechnology industry
What country is Arcutis Biotherapeutics, Inc. based in?
Arcutis Biotherapeutics, Inc. is headquartered in United States
When did Arcutis Biotherapeutics, Inc. go public?
Arcutis Biotherapeutics, Inc. initial public offering (IPO) was on January 31, 2020
Is Arcutis Biotherapeutics, Inc. in the S&P 500?
No, Arcutis Biotherapeutics, Inc. is not included in the S&P 500 index
Is Arcutis Biotherapeutics, Inc. in the NASDAQ 100?
No, Arcutis Biotherapeutics, Inc. is not included in the NASDAQ 100 index
Is Arcutis Biotherapeutics, Inc. in the Dow Jones?
No, Arcutis Biotherapeutics, Inc. is not included in the Dow Jones index
When was Arcutis Biotherapeutics, Inc. last earnings report?
Arcutis Biotherapeutics, Inc.'s most recent earnings report was on February 25, 2026
When does Arcutis Biotherapeutics, Inc. report earnings?
The next expected earnings date for Arcutis Biotherapeutics, Inc. is May 5, 2026
Data Sources & References
- ARQT Official Website www.arcutis.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1787306/000178730626000018/0001787306-26-000018-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1787306/000178730626000018/0001787306-26-000018-index.htm
- ARQT Profile on Yahoo Finance finance.yahoo.com/quote/ARQT
- ARQT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arqt